AFib for Professionals

Atrial Fibrillation Incidence and Prevalence

Cardiac rhythm disorders are common, with atrial fibrillation (AF) being the most common form of arrhythmia.
The prevalence of AF in the United States (US) is estimated to rise from ≈5.2 million in 2010 to 12.1 million in 2030. Data from a health insurance claims database covering 5% of the US found the incidence of AF was estimated at 1.2 million new cases in 2010 and projected it to increase to 2.6 million new cases in 2030. The lifetime risk of AF in the US is about ≈1 in 3 in Whites and ≈1 in 5 in Blacks. Even with current guideline-based management, AF patients have stroke, acute coronary syndrome, heart failure, and cardiovascular death at a rate of approximately 5% of patients per year, and 35 to 50% of patients with AF who receive adequate anticoagulation either receive inpatient therapy or die within 5 years.

Videos on Demand

CE and MOC Credits Available
Close up of patient and doctor taking notes

Updates in Guideline-Directed Antiarrhythmic Medications in AFib

Watch a discussion on AFib management strategies in people with comorbidities and special populations, including pharmacological agents for rhythm and rate control as well as treatment objectives. CE and MOC credits available.
Watch Updates in Guideline-Directed Antiarrhythmic Medications

Podcasts

Breaking the Clot Code:

A Deep Dive into Anticoagulation in Non-valvular Atrial Fibrillation

In this podcast we aim to highlight and discuss the updated evidence regarding stroke prevention in patients with non-valvular atrial fibrillation (NVAF), we will explore the indications for starting anticoagulation upon diagnosis of NVAF, as well as evidence of stopping and restarting anticoagulation for procedures. Listen Now!

Claim CE and MOC Credits: Breaking the Clot Code

Clot Matters:

Navigating Atrial Fibrillation Anticoagulation in Special Populations

We will provide a case-based approach to these challenging situations with multidisciplinary perspectives from pharmacy and cardiology. Listen Now!

Claim CE and MOC Credits: Clot Matters

When Medication is Not Tolerated or Not Enough:

Interventional and Surgical Approaches to Atrial Fibrillation

We will provide a review of interventional approaches including AF ablation for the management of atrial fibrillation and briefly discuss left atrial occlusion devices. Listen Now!

Claim CE and MOC Credits: When Medication is Not Tolerated

Heart In Sync:

A-Fib and Lifestyle Links

We will discuss the current evidence related to common patient-reported triggers, as well as the latest evidence-based guidelines related to risk factor modification for prevention of AF onset, slowing of AF progression, and improved AF-related outcomes. Listen Now!

Claim CE and MOC Credits: Heart in Sync

Additional Resources

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses

Learn more about Professional Membership

laptop with stethoscope
Become a Member
Already a member and need to renew?